Lombard Medical CEO Hubbert, CFO Kullback step down | Personnel Moves, April 28, 2017

Lombard Medical Technologies (NSDQ:EVAR) said this month that its CEO Simon Hubbert and CFO William Kullback are stepping down from their positions, with Kurt Lemvigh stepping into the CEO role. Hubbert served as CEO for 6 years after joining the company in 2010, and will be replaced by Lemvigh, who has held positions with multiple companies, including Cardiac Science and GE (NYSE:GE). “Lombard represents a unique opportunity given the strength of the company’s portfolio in the over $1.5 billion market for endovascular repair products. The key to success will be our ability to leverage the work that has been done over the years and moreover, to achieve operational excellence. For my part, I am committed to creating value for all of the stakeholders of Lombard,” Lemvigh said in a prepared statement. “Simon made many significant contributions during his six years as CEO of Lombard including expanding the company’s product portfolio and geographic reach. On behalf of the board and shareholders, we thank Simon for his contributions and diligent efforts during a time of significant change in the endovascular aneurysm repair market. We wish him well in his future endeavors,” board chair Raymond Cohen said in a press release. Kullback’s resignation was part of the company’s discontinuation of commercial operations in the US, the company said, and not the result of any disagreements with the company. Kullback will be moving on to “pursue a new...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Business/Financial News Accuray Inc. Becton Dickinson & Co. Boston Scientific Cardiac Sciences Corp. ConMed Corp. Fresenius GE Healthcare Lombard Medical Technologies Magnolia Medical Technologies ReWalk Robotics Senseonics Toshiba Source Type: news